Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
13 hedge funds and large institutions have $172K invested in Acer Therapeutics Inc in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
27% less capital invested
Capital invested by funds: $237K → $172K (-$65K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$18.3K |
| 2 |
Bank of New York Mellon
New York
|
+$12.6K |
| 3 |
BlackRock
New York
|
+$325 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$27.2K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$21K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12K |
| 4 |
FPF
FNY Partners Fund
New York
|
-$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$769 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $54K | -$12K | -1,810 | -19% |
|
2
California Public Employees Retirement System
Sacramento,
California
| $43K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $23K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $19K | +$18.3K | +2,758 | New |
|
|
5
Bank of New York Mellon
New York
| $13K | +$12.6K | +1,901 | New |
|
|
VKH
6
Virtu KCG Holdings
New York
| $11K | -$27.2K | -4,098 | -71% |
|
|
7
UBS Group
Zurich,
Switzerland
| $5K | -$769 | -116 | -13% |
|
|
8
BlackRock
New York
| $2K | +$325 | +49 | +17% |
|
9
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
10
Morgan Stanley
New York
| $1K | – | – | – |
|
|
ARTA
11
A.R.T. Advisors
New York
| – | -$21K | -2,673 | Closed |
|
|
FPF
12
FNY Partners Fund
New York
| – | -$1K | -192 | Closed |
|
ACER Hedge Fund Activity: Q2 2017 in Review
13 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2017, worth a combined $172K — down 27% from $237K a quarter earlier.
Fund positioning in ACER was balanced in Q2 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $18.3K. The largest seller was Virtu KCG Holdings, cutting an estimated $27.2K.
- 13 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $172K of Acer Therapeutics Inc stock for Q2 2017, down 27% quarter-over-quarter.
- 2 funds opened new Acer Therapeutics Inc positions in Q2 2017 and 2 closed out, a net change of 0 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2017 was Two Sigma Securities, an estimated $18.3K added.
- The largest Acer Therapeutics Inc seller in Q2 2017 was Virtu KCG Holdings, an estimated $27.2K sold.
Based on aggregated 13F filings for Q2 2017.